Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination

INTRODUCTION: During the COVID-19 pandemic, certain disease modifying therapies (DMTs) used in multiple sclerosis (MS), such as anti-CD20 therapies, have been associated with decreased humoral responses after SARS-CoV-2 vaccination. Hybrid immunity, referring to immunity after both vaccination and S...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dam, Koos P. J., Hogenboom, Laura, Stalman, Eileen W., Kummer, Laura Y. L., Steenhuis, Maurice, Keijser, Jim B. D., Brinke, Anja ten, van Ham, S. Marieke, Kuijpers, Taco W., Rispens, Theo, Wieske, Luuk, Eftimov, Filip, Strijbis, Eva M., Killestein, Joep, van Kempen, Zoé L. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686308/
https://www.ncbi.nlm.nih.gov/pubmed/36438945
http://dx.doi.org/10.3389/fneur.2022.1032830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686308/
https://www.ncbi.nlm.nih.gov/pubmed/36438945
http://dx.doi.org/10.3389/fneur.2022.1032830

Ejemplares similares